These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21098035)

  • 1. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
    Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
    J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
    Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
    Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
    Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
    Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of H2AX at Ser139 and a new phosphorylation site Ser16 by RSK2 decreases H2AX ubiquitination and inhibits cell transformation.
    Zhu F; Zykova TA; Peng C; Zhang J; Cho YY; Zheng D; Yao K; Ma WY; Lau AT; Bode AM; Dong Z
    Cancer Res; 2011 Jan; 71(2):393-403. PubMed ID: 21224359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
    Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
    BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of histone H2B serine 32 is linked to cell transformation.
    Lau AT; Lee SY; Xu YM; Zheng D; Cho YY; Zhu F; Kim HG; Li SQ; Zhang Z; Bode AM; Dong Z
    J Biol Chem; 2011 Jul; 286(30):26628-37. PubMed ID: 21646345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.
    Kim HG; Lee KW; Cho YY; Kang NJ; Oh SM; Bode AM; Dong Z
    Cancer Res; 2008 Apr; 68(7):2538-47. PubMed ID: 18381464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
    Choi JS; Cho YY
    Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
    Roux PP; Richards SA; Blenis J
    Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression.
    Gupta P; Prywes R
    J Biol Chem; 2002 Dec; 277(52):50550-6. PubMed ID: 12414794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
    Cho YY
    Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p38 Mitogen-activated protein kinase regulation of JB6 Cl41 cell transformation promoted by epidermal growth factor.
    He Z; Cho YY; Liu G; Ma WY; Bode AM; Dong Z
    J Biol Chem; 2003 Jul; 278(29):26435-42. PubMed ID: 12748197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A regulatory mechanism for RSK2 NH(2)-terminal kinase activity.
    Cho YY; Yao K; Pugliese A; Malakhova ML; Bode AM; Dong Z
    Cancer Res; 2009 May; 69(10):4398-406. PubMed ID: 19435896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
    Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
    J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ribosomal S6 kinase 2 (RSK2)-SPRED2 complex regulates the phosphorylation of RSK substrates and MAPK signaling.
    Lopez J; Bonsor DA; Sale MJ; Urisman A; Mehalko JL; Cabanski-Dunning M; Castel P; Simanshu DK; McCormick F
    J Biol Chem; 2023 Jun; 299(6):104789. PubMed ID: 37149146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.
    Kang S; Dong S; Gu TL; Guo A; Cohen MS; Lonial S; Khoury HJ; Fabbro D; Gilliland DG; Bergsagel PL; Taunton J; Polakiewicz RD; Chen J
    Cancer Cell; 2007 Sep; 12(3):201-14. PubMed ID: 17785202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RSK2 as a key regulator in human skin cancer.
    Cho YY; Lee MH; Lee CJ; Yao K; Lee HS; Bode AM; Dong Z
    Carcinogenesis; 2012 Dec; 33(12):2529-37. PubMed ID: 22918890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.
    Peng C; Zhu F; Wen W; Yao K; Li S; Zykova T; Liu K; Li X; Ma WY; Bode AM; Dong Z
    J Biol Chem; 2012 Jul; 287(31):25881-92. PubMed ID: 22685297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.
    Lee KW; Kang NJ; Rogozin EA; Oh SM; Heo YS; Pugliese A; Bode AM; Lee HJ; Dong Z
    Int J Cancer; 2008 Dec; 123(11):2487-96. PubMed ID: 18767048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.